Transport of Rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A- related compounds

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 149-155

  Yumoto, Ryoko ^a   Murakami, Teruo ^a   Nakamoto, Yuko ^a   Hasegawa, Risa ^a   Nagai, Junya ^a   Takano, Mikihisa ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ERYTHROMYCIN; KETOCONAZOLE; MIDAZOLAM; QUINIDINE; RHODAMINE 123; VERAPAMIL;

ACTIVE TRANSPORT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG UPTAKE; HUMAN; HUMAN CELL; ILEUM; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE ABSORPTION;

EID: 0032951089     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ameer B and Weintraub RA (1997) Drug interactions with grapefruit juice. Clin Pharmacokinet 33:103-121.
2. Chianale J, Vollrath V, Wielandt AM, Miranda S. Gonzalez R., Fresno AM, Quintana C, Gonzalez S, Andrade L and Guzman S (1995) Differences between nuclear run-off and mRNA levels for multidrug resistance gene expression in the cephalocaudal axis of the mouse intestine. Biochim Biophys Acta 1264:369-376.
3. Frömter E and Diamond J (1972) Route of passive ion permeation in epithelia. Nature [New Biol] 235:9-13.
4. Guengerich FP (1992) Characterization of human cytochrome P450 enzymes. FASEB J 6:745-748.
5. Harada S, Murakami T, Higashi Y, Takano M and Yata N (1997) Enhancing mechanism of decanoic acid for the permeation of water-soluble compounds through Caco-2 cell monolayers. Pharm Sci 3:175-178.
6. Holash JA and Stewart PA (1993) The relationship of astrocyte-like cells to the vessels that contribute to the blood-ocular barriers. Brain Res 629:218-224.
7. Hsing S, Gatmaitan Z and Arias IM (1992) The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 102:879-885.
8. Hunter J, Hirst BH and Simmons NL (1993) Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm Res 10:743-749.
9. Kupferschmidt HHT, Ha HR, Ziegler WH, Meier PJ and Krähenbühl S (1995) Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther 58:20-28.
10. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT and Bates SE (1994) Rhodamine efflux patterns predict p-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharmacol 46:627-638.
11. Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA and Watkins PB (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: Lack of prediction by the erythromycin breath test. Drug Metab Dispos 22:947-955.
12. Nagai J, Takano M, Hirozane K, Yasuhara M and Inui K (1995) Specificity of p-aminohippurate transport system in the OK kidney epithelial cell line. J Pharmacol Exp Ther 274:1161-1166.
13. Olkkola KT, Backman JT and Neuvonen PJ (1994) Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole. Clin Pharmacol Ther 55:481-485.
14. Paine MF, Shen DD, Kunze KL, Perkins JD, Marsh CL, McVicar JP, Barr DM, Gillies BS and Thummel KE (1996) First-pass metabolism of midazolam by the hitman intestine. Clin Pharmacol Ther 60:14-24.
15. Porter TD and Coon MJ (1991) Cytochrome P-450: Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266:13469-13472.
16. Schuetz EG, Beck WT and Schuetz JD (1996a) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311-318.
17. Schuetz EG, Schinkel AH, Relling MV and Schuetz JD (1996b) P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci USA 93:4001-4005.
18. Sweatman TW, Seshadri R and Israel M (1990) Metabolism and elimination of rhodamine 123 in the rat. Cancer Chemother Pharmacol 27:205-210.
19. Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J and Murakami T (1998) Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. Eur J Pharmacol 358:289-294.
20. Terao T, Hisanaga E, Sai Y, Tamai I and Tsuji A (1996) Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J Pharm Pharmacol 48:1083-1089.
21. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I and Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738.
22. Thummel KE, O'Shea D, Paine M F, Shen DD, Kunze KL, Perkins JD and Wilkinson GR (1996) Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 59:491-502.
23. Trezise AE, Romano PR, Gill DR, Hyde SC, Sepulveda FV, Buchwald M and Higgins CF (1992) The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J 11:4291-4303.
24. Tsuji A and Tamai I (1996) Carrier-mediated intestinal transport of drugs. Pharm Res 13:963-977.
25. Wacher VJ, Wu CY and Benet LZ (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129-134.
26. Wils P, Phung-Ba V, Warnery A, Lechadeur D, Raeissi S, Hidalgo IJ and Scherman D (1994) Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem Pharmacol 48:1528-1530.
27. +-hydroxy midazolam formation by ketoconazole, nifedipine, erythromycin, cimetidine, and nizatidine. Pharm Res 11:921-924.
28. Yee S (1997) In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in human: Fact or myth? Pharm Res 14:763-766.